POM-V Prescription Required

Qivitan 25 mg/ml Suspension for Injection for Cattle and Pigs

Active ingredient: Cefquinome

Form

Injection

Species

Cattle Pigs

Manufacturer

Industrial Veterinaria SA

VMD MA No.

36547/3009

What it's used for

Cattle: Respiratory disease caused by Pasteurella multocida and Mannheimia haemolytica. Digital dermatitis, infectious bulbar necrosis and acute interdigit...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Cefquinome

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Qivitan 25 mg/ml Suspension for Injection for Cattle and Pigs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Cattle:
Respiratory disease caused by Pasteurella multocida and Mannheimia haemolytica.
Digital dermatitis, infectious bulbar necrosis and acute interdigital necrobacillosis (foul
in the foot).
Acute E.coli mastitis with signs of systemic involvement.
Calves:
E.coli septicaemia in calves.
Pigs:
For the treatment of bacterial infections of the lungs and respiratory tract caused by
Pasteurella multocida, Haemophilus parasuis, Actinobacillus pleuropneumoniae,
Streptococcus suis and other cefquinome-sensitive organisms.
Mastitis-Metritis-Agalactia syndrome (MMA) with involvement of
Staphylococcus spp., Streptococcus spp. and other cefquinome sensitive organisms.
Piglets:
Reduction of mortality in cases of meningitis caused by Streptococcus suis.
For the treatment of:
Arthritis caused by , E. coli
organisms.
Epidermitis (mild or moderate lesions) caused by Staphylococcus hyicus.

SpeciesIndicationDosageFrequencyCattleRespiratory disease
caused by
multocida and M.
haemolytica
1 mg cefquinome/kg bw
(2 ml/50 kg bw)
Once daily for 3
to 5 consecutive
days
Digital dermatitis,
infectious bulbar
necrosis and acute
interdigital
necrobacillosis (foul in
the foot)
Acute E. coli mastitis
with signs of systemic
involvement
1 mg cefquinome/kg bw
(2 ml/50 kg bw)
Once daily for 2
consecutive
days
CalvesE. coli septicaemia2 mg cefquinome/kg bw
(4 ml/50 kg bw)
Once daily for 3
to 5 consecutive
days
Pigs Respiratory disease2 mg cefquinome/kg bw
(2 ml/25 kg bw)
Once daily for 3
consecutive
days.
MMA2 mg cefquinome/kg bw
(2 ml/25 kg bw)
Once daily for 2
consecutive
days.
PigletsMeningitis
Arthritis
Epidermitis
2 mg cefquinome/kg bw
(2 ml/25 kg bw)
Once daily for 5
consecutive
days
Studies have indicated the advisability of giving second and subsequent injections at
different injection sites. The preferred injection site is in the muscular tissue of the
mid neck.
To ensure a correct dosage, body weight should be determined as accurately as
possible.
Shake the vial well before using.
The veterinary medicinal product does not contain an antimicrobial preservative.
Swab the septum before removing each dose. Use a dry sterile needle and syringe.
An appropriately graduated syringe must be used to allow accurate administration of
the required dose volume. This is particularly important when injecting small volumes,
for example when treating piglets. When treating groups of animals, use a draw-off
needle.
The rubber stopper of the vial may be safely punctured up to 50 times.

Do not use in cases of hypersensitivity to the active substance, ß-lactam antibiotics,
or to any of the excipients.
Do not use in animals less than 1.25 kg body weight.
Do not use in poultry (including eggs) due to risk of spread of antimicrobial resistance
to humans.

Cattle and pigs:
Rare
(1 to 10 animals / 10,000
animals treated):
Hypersensitivity reactionUndetermined frequency
(cannot be estimated from the
available data):
Injection site reaction, Injection site lesion
1
Lesions are repaired 15 days after last administration.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.

None.

Special precautions for safe use in the target species:
In case of occurrence of allergic reaction, the treatment should be withdrawn.
The use of cefquinome should be restricted to appropriate use according to the
labelled indications in the target animal species.
The veterinary medicinal product selects for resistant strains such as bacteria
carrying extended spectrum betalactamases (ESBL) which may constitute a risk to
human health if these strains disseminate to humans e.g. via food. For this reason,
the veterinary medicinal product should be reserved for the treatment of clinical
conditions which have responded poorly, or are expected to respond poorly (refers to
very acute cases when treatment must be initiated without bacteriological diagnosis),
to first line treatment.
Official, national and regional antimicrobial policies should be taken into account
when the product is used. Increased use, including use of the product deviating from
the instructions given in the SPC, may increase the prevalence of such resistance.
Whenever possible, the product should only be used based on susceptibility testing.
Inappropriate use of the product may increase the prevalence of bacteria resistant to
cefquinome and may decrease the effectiveness of treatment with other beta lactam
antibiotics, due to the potential for cross resistance.
The veterinary medicinal product is intended for treatment of individual animals. Do
not use for disease prevention or as a part of herd health programs. Treatment of
groups of animals should be strictly restricted to ongoing disease outbreaks
according to the approved conditions of use.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
- Cephalosporins may cause hypersensitivity (allergy) following injection, inhalation,
ingestion or skin contact. Hypersensitivity to penicillins may lead to cross sensitivity
to cephalosporins and vice versa. Allergic reactions to these substances may
occasionally be serious.
- People with known hypersensitivity to cefquinome sulfate should avoid contact with
the veterinary medicinal product.
- Handle this veterinary medicinal product with great care to avoid exposure, taking
all recommended precautions.
- If you develop symptoms following exposure such as a skin rash, seek medical
advice and show the package leaflet or the label to the physician. Swelling of the
face, lips or eyes or difficulty with breathing, are more serious symptoms and require
urgent medical attention.
- Wash hands after use.
Special precautions for the protection of the environment:
Not applicable.

Due to an undesirable pharmacodynamic interaction, do not use cefquinome
simultaneously with pharmaceuticals acting bacteriostatically.

Protect from light.

Cattle:Meat and offal: 5 days
Milk: 24 hours
Pigs: Meat and offal: 3 days

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.